Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
Research output: Contribution to journal › Article
Research Projects
Acute Myeloid Leukaemia Trials; Long-term follow-up, analysis and reporting
MEDICAL RESEARCH COUNCIL
1/10/03 → 30/09/09
Project: Research Councils